nivolumab,ipilimumab,pembrolizumab
bms,merck
['pemetrexed', 'lung', 'pembro']
 lovely data. eventually, keep an eye out for the results of the newly opened uk study, refine-lung. looking at dose de-escalation post 6/12 in patients receiving pembrolizumab (either as mono or along with pemetrexed). q12w dosing. able to go back to soc dosing if progression
Consultant medical oncologist @ ICHNT (Thoracic Oncology and Acute Oncology), Honorary Senior Clinical Lecturer @ IC.’Slightly’ (!) tired mum to the fab Mr9.